ロード中...
The 315–316 deletion determines the BXP-21 antibody epitope but has no effect on the function of wild type ABCG2 or the Q141K variant
ABCG2 is a half-transporter initially described in multidrug-resistant cancer cells and lately identified as an important factor in the pharmacokinetics of its substrates. Q141K is by far the most intensively studied single nucleotide polymorphism of ABCG2 with potential clinical relevance. Here we...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2631614/ https://ncbi.nlm.nih.gov/pubmed/19002564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11010-008-9940-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|